卡塔尔多发性硬化症的患病率、人口统计学特征及临床特点
Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar.
作者信息
Deleu Dirk, Mir Danial, Al Tabouki Ahmed, Mesraoua Rim, Mesraoua Boulenouar, Akhtar Naveed, Al Hail Hassan, D'souza Atlantic, Melikyan Gayane, Imam Yahia Z B, Osman Yasir, Elalamy Osama, Sokrab Tageldin, Kamran Sadaat, Ruiz Miyares Francisco, Ibrahim Faiza
机构信息
Department of Neurology (Medicine), Hamad Medical Corporation, Doha, Qatar.
出版信息
Mult Scler. 2013 May;19(6):816-9. doi: 10.1177/1352458512459291. Epub 2012 Sep 11.
No published epidemiologic data on multiple sclerosis (MS) in Qatar exist. Our objectives were to determine the prevalence, demographics and clinical characteristics of MS in the Middle Eastern country of Qatar. We analyzed data for Qatari MS patients fulfilling the McDonald diagnostic criteria. A total of 154 patients fulfilled the inclusion criteria. On 31 April 2010, the crude prevalence of MS in Qatar was 64.57 per 100,000 inhabitants (95% CI: 58.31-70.37). The female-to-male ratio was 1.33:1. A positive family history was found in 10.4% of included MS patients. We conclude that Qatar is now a medium-to-high risk area for MS, with some important differences in clinical characteristics as compared to other countries in the region.
卡塔尔没有关于多发性硬化症（MS）的已发表流行病学数据。我们的目标是确定中东国家卡塔尔MS的患病率、人口统计学特征和临床特征。我们分析了符合麦克唐纳诊断标准的卡塔尔MS患者的数据。共有154名患者符合纳入标准。2010年4月31日，卡塔尔MS的粗患病率为每10万居民64.57例（95%置信区间：58.31 - 70.37）。女性与男性比例为1.33:1。在纳入的MS患者中，10.4%有阳性家族史。我们得出结论，卡塔尔现在是MS的中高风险地区，与该地区其他国家相比，临床特征存在一些重要差异。
Zotero 插件